Literature DB >> 33278112

Epidemiologic trends and characteristics of SARS-CoV-2 infections among children in the United States.

Danielle A Rankin1,2, Rana Talj1, Leigh M Howard1, Natasha B Halasa1.   

Abstract

PURPOSE OF REVIEW: To review the epidemiological characteristics and clinical features associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among children in the United States. RECENT
FINDINGS: In the United States, the majority of SARS-CoV-2 infections in children have been mild illnesses, with those 5-17 years of age having the highest frequency. Specifically, the incidence of SARS-CoV-2 in children is two times higher in adolescents (12-17 years) than younger school-aged children (5-11 years). Despite the higher case counts in older children, 10% of pediatric hospitalizations have been in infants less than one year. In addition, severe respiratory and renal complications, hospitalization, and even death have been documented in children.
SUMMARY: Clinical manifestations of SARS-CoV-2 infection in children range from asymptomatic to severe respiratory distress, with mild nonspecific symptoms being the most commonly reported. The broad clinical presentation and the frequency of asymptomatic or minimally symptomatic infections in children pose challenges for controlling and detecting SARS-CoV-2. However, severe disease has been noted in children with associated medical complications and death. Thus, additional active surveillance and research is needed to understand the burden children contribute to the SARS-CoV-2 pandemic in the United States.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33278112      PMCID: PMC8011299          DOI: 10.1097/MOP.0000000000000971

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  8 in total

1.  Severe Outcomes Associated With SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis.

Authors:  Madeleine W Sumner; Alicia Kanngiesser; Kosar Lotfali-Khani; Nidhi Lodha; Diane Lorenzetti; Anna L Funk; Stephen B Freedman
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

Review 2.  Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era.

Authors:  Vinicius A Vieira; Nicholas Herbert; Gabriela Cromhout; Emily Adland; Philip Goulder
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

3.  Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques.

Authors:  Cyril Le Nouën; Christine E Nelson; Xueqiao Liu; Hong-Su Park; Yumiko Matsuoka; Cindy Luongo; Celia Santos; Lijuan Yang; Richard Herbert; Ashley Castens; Ian N Moore; Temeri Wilder-Kofie; Rashida Moore; April Walker; Peng Zhang; Paolo Lusso; Reed F Johnson; Nicole L Garza; Laura E Via; Shirin Munir; Daniel Barber; Ursula J Buchholz
Journal:  bioRxiv       Date:  2022-05-23

Review 4.  Experimental Models of COVID-19.

Authors:  Luis A Caldera-Crespo; Michael J Paidas; Sabita Roy; Carl I Schulman; Norma Sue Kenyon; Sylvia Daunert; Arumugam R Jayakumar
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

5.  Outcomes of SARS-CoV-2-Positive Youths Tested in Emergency Departments: The Global PERN-COVID-19 Study.

Authors:  Anna L Funk; Todd A Florin; Nathan Kuppermann; Daniel J Tancredi; Jianling Xie; Kelly Kim; Mark I Neuman; Lilliam Ambroggio; Amy C Plint; Santiago Mintegi; Terry P Klassen; Marina I Salvadori; Richard Malley; Daniel C Payne; Norma-Jean Simon; Adriana Yock-Corrales; Jasmine R Nebhrajani; Pradip P Chaudhari; Kristen A Breslin; Yaron Finkelstein; Carmen Campos; Kelly R Bergmann; Maala Bhatt; Fahd A Ahmad; Michael A Gardiner; Usha R Avva; Nipam P Shah; Laura F Sartori; Vikram J Sabhaney; Kerry Caperell; Nidhya Navanandan; Meredith L Borland; Claudia R Morris; Iker Gangoiti; Viviana Pavlicich; Nirupama Kannikeswaran; Maren M Lunoe; Pedro B Rino; April J Kam; Jonathan C Cherry; Alexander J Rogers; Shu-Ling Chong; Laura Palumbo; Carlos M Angelats; Andrea K Morrison; Maria Y Kwok; Sarah M Becker; Andrew C Dixon; Naveen Poonai; Michelle Eckerle; Muhammad Wassem; Stuart R Dalziel; Stephen B Freedman
Journal:  JAMA Netw Open       Date:  2022-01-04

6.  Epidemiological Characteristics and Transmission Patterns of COVID-19 Cases Among Children and Adolescents Aged 0-18 Years in South Korea.

Authors:  Jinhwa Jang; Myung-Jae Hwang; Yoo-Yeon Kim; Shin Young Park; Myeongsu Yoo; Seong-Sun Kim; Sangwon Lee; Donghyok Kwon
Journal:  Risk Manag Healthc Policy       Date:  2022-02-09

7.  A COVID-19 primer for primary care clinicians.

Authors:  Mary Carol Burkhardt; Kathleen Winter; Sherman J Alter; J Michael Klatte
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2022-03-14

8.  Effectiveness Associated With BNT162b2 Vaccine Against Emergency Department and Urgent Care Encounters for Delta and Omicron SARS-CoV-2 Infection Among Adolescents Aged 12 to 17 Years.

Authors:  Sara Y Tartof; Timothy B Frankland; Jeff M Slezak; Laura Puzniak; Vennis Hong; Fagen Xie; Bradley K Ackerson; Srinivas R Valluri; Luis Jodar; John M McLaughlin
Journal:  JAMA Netw Open       Date:  2022-08-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.